Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

14

Revenue 2017

Opdivo

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Opdivo was produced by Gilead Sciences.

Merck’s Keytruda picks up third approval for NSCLC in China

Merck’s Keytruda picks up third approval for NSCLC in China However, it was not the first PD-1 inhibitor to get a green light in the country – Bristol-Myers Squibb won that prize for Opdivo (nivolumab) in NSCLC back in 2018.

Roche’s Tecentriq/Avastin combo improves survival in liver cancer

Roche’s Tecentriq/Avastin combo improves survival in liver cancer HCC could be another important indication for Tecentriq as it plays catch-up in the cancer immunotherapy market with Merck &Co/MSD’s Keytruda (pembrolizumab) and Bristol-Myers Squibb’s Opdivo ... BMS meanwhile reported data a few months ago from the

BMS’ Opdivo/Yervoy combination fails to shine in melanoma

BMS’ Opdivo/Yervoy combination fails to shine in melanoma Bristol-Myers Squibb has faced a bump in the road of its expansion plans for Opdivo/Yervoy, after the combination failed to demonstrate a significant benefit in certain high-risk melanoma ... However, BMS has recently  announced positive results from

MSD’s Keytruda scores another EU okay, in head and neck cancer

MSD’s Keytruda scores another EU okay, in head and neck cancer new treatment option and MSD’s drug another leg up over its rivals in the checkpoint inhibitor category such as Bristol-Myers Squibb’s Opdivo (nivolumab). ... Keytruda also overtakes Opdivo in HNSCC, which at the moment is only approved as a

BMS scores FDA priority review for Opdivo/Yervoy combo in liver cancer

BMS scores FDA priority review for Opdivo/Yervoy combo in liver cancer BMS has previously evaluated Opdivo as a monotherapy treatment in front-line lung cancer, although its efforts in this area were fruitless. ... However, BMS is likely hoping that its upcoming $74bn takeover of Celgene will reduce its reliance on Opdivo

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

customer engagement 1
Building meaningful customer engagement through data-driven digital insights
Understanding the helpful insights that online HCP conversations can reveal...
4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...

Infographics